Found: 47
Select item for more details and to access through your institution.
Author Correction: Reversal of pre-existing NGFR-driven tumor and immune therapy resistance.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Human papillomavirus-negative epithelial proliferations resembling condylomata acuminata in a patient receiving vemurafenib for Stage IV melanoma.
- Published in:
- 2020
- By:
- Publication type:
- case study
Long-Term Survival in Patients With Advanced Melanoma.
- Published in:
- JAMA Network Open, 2024, v. 7, n. 8, p. e2426641, doi. 10.1001/jamanetworkopen.2024.26641
- By:
- Publication type:
- Article
Case Report of a Fatal Serious Adverse Event Upon Administration of T Cells Transduced With a MART-1-specific T-cell Receptor.
- Published in:
- Molecular Therapy, 2015, v. 23, n. 9, p. 1541, doi. 10.1038/mt.2015.60
- By:
- Publication type:
- Article
Dermal Delivery of Constructs Encoding Cre Recombinase to Induce Skin Tumors in Pten<sup>LoxP/LoxP</sup>;Braf<sup>CA/+</sup> Mice.
- Published in:
- International Journal of Molecular Sciences, 2016, v. 17, n. 12, p. 2149, doi. 10.3390/ijms17122149
- By:
- Publication type:
- Article
Intra- and inter-tumor heterogeneity in a vemurafenib-resistant melanoma patient and derived xenografts.
- Published in:
- EMBO Molecular Medicine, 2015, v. 7, n. 9, p. 1104, doi. 10.15252/emmm.201404914
- By:
- Publication type:
- Article
ASO Visual Abstract: Is a History of Optimal Staging by SLNB in the Era Prior to Adjuvant Therapy Associated with Improved Outcome Once Melanoma Patients have Progressed to Advanced Disease?
- Published in:
- 2023
- By:
- Publication type:
- Abstract
Is a History of Optimal Staging by Sentinel Lymph Node Biopsy in the Era Prior to Adjuvant Therapy Associated with Improved Outcome Once Melanoma Patients have Progressed to Advanced Disease?
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2023, v. 30, n. 1, p. 573, doi. 10.1245/s10434-022-12600-2
- By:
- Publication type:
- Article
Correction to: Neoadjuvant Systemic Therapy (NAST) in Patients with Melanoma: Surgical Considerations by the International Neoadjuvant Melanoma Consortium (INMC).
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Neoadjuvant Systemic Therapy (NAST) in Patients with Melanoma: Surgical Considerations by the International Neoadjuvant Melanoma Consortium (INMC).
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2022, v. 29, n. 6, p. 3694, doi. 10.1245/s10434-021-11236-y
- By:
- Publication type:
- Article
Phase Ib Study of Atezolizumab Plus Interferon-β with or without Bevacizumab in Patients with Metastatic Renal Cell Carcinoma and Other Solid Tumors.
- Published in:
- Current Oncology, 2021, v. 28, n. 6, p. 5466, doi. 10.3390/curroncol28060455
- By:
- Publication type:
- Article
Failure to validate existing clinical prediction scale for response to PD-1 monotherapy in advanced melanoma in national cohort study.
- Published in:
- 2023
- By:
- Publication type:
- Letter
Correction: First-line BRAF/MEK inhibitors versus anti-PD-1 monotherapy in BRAF<sup>V600</sup>-mutant advanced melanoma patients: a propensity-matched survival analysis.
- Published in:
- 2022
- By:
- Publication type:
- corrected article
Correction: First-line BRAF/MEK inhibitors versus anti-PD-1 monotherapy in BRAF<sup>V600</sup>-mutant advanced melanoma patients: a propensity-matched survival analysis.
- Published in:
- 2021
- By:
- Publication type:
- corrected article
First-line BRAF/MEK inhibitors versus anti-PD-1 monotherapy in BRAF<sup>V600</sup>-mutant advanced melanoma patients: a propensity-matched survival analysis.
- Published in:
- 2021
- By:
- Publication type:
- journal article
The effect of seasonal variation and secretion of sunitinib in sweat on the development of hand–foot syndrome.
- Published in:
- European Journal of Clinical Pharmacology, 2013, v. 69, n. 12, p. 2065, doi. 10.1007/s00228-013-1579-4
- By:
- Publication type:
- Article
Representativeness of the Index Lymph Node for Total Nodal Basin in Pathologic Response Assessment After Neoadjuvant Checkpoint Inhibitor Therapy in Patients With Stage III Melanoma.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Acidity‐mediated induction of FoxP3<sup>+</sup> regulatory T cells.
- Published in:
- European Journal of Immunology, 2023, v. 53, n. 6, p. 1, doi. 10.1002/eji.202250258
- By:
- Publication type:
- Article
Ipilimumab in pretreated metastastic uveal melanoma patients. Results of the Dutch Working group on Immunotherapy of Oncology (WIN-O)
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Ipilimumab in pretreated metastastic uveal melanoma patients. Results of the Dutch Working group on Immunotherapy of Oncology (WIN-O).
- Published in:
- 2013
- By:
- Publication type:
- Letter
Interferon-induced programmed death-ligand 1 ( PD- L1/ B7- H1) expression increases on human acute myeloid leukemia blast cells during treatment.
- Published in:
- European Journal of Haematology, 2014, v. 92, n. 3, p. 195, doi. 10.1111/ejh.12228
- By:
- Publication type:
- Article
BRAF/MEK inhibitor rechallenge in advanced melanoma patients.
- Published in:
- Cancer (0008543X), 2024, v. 130, n. 9, p. 1673, doi. 10.1002/cncr.35178
- By:
- Publication type:
- Article
Therapeutic use of anti-CTLA-4 antibodies
- Published in:
- International Immunology, 2015, v. 27, n. 1, p. 3, doi. 10.1093/intimm/dxu076
- By:
- Publication type:
- Article
Advanced Melanoma: Current Treatment Options, Biomarkers, and Future Perspectives.
- Published in:
- American Journal of Clinical Dermatology, 2018, v. 19, n. 3, p. 303, doi. 10.1007/s40257-017-0325-6
- By:
- Publication type:
- Article
Switch to checkpoint inhibition after targeted therapy at time of progression or during ongoing response: A retrospective single‐centre experience in patients with BRAF‐mutated melanoma.
- Published in:
- Pigment Cell & Melanoma Research, 2020, v. 33, n. 3, p. 498, doi. 10.1111/pcmr.12835
- By:
- Publication type:
- Article
Personalized Neoadjuvant Immunotherapy Combinations Improve Outcomes in Stage III Melanoma.
- Published in:
- Journal of Oncology Navigation & Survivorship, 2019, v. 10, n. 10, p. 414
- By:
- Publication type:
- Article
Safety and Efficacy of Checkpoint Inhibition in Patients With Melanoma and Preexisting Autoimmune Disease : A Cohort Study.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Long-Term Survival, Quality of Life, and Psychosocial Outcomes in Advanced Melanoma Patients Treated with Immune Checkpoint Inhibitors.
- Published in:
- Journal of Oncology, 2019, p. 1, doi. 10.1155/2019/5269062
- By:
- Publication type:
- Article
Metabolic profiles of regulatory T cells in the tumour microenvironment.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 9, p. 2417, doi. 10.1007/s00262-021-02881-z
- By:
- Publication type:
- Article
Targeting tumor-associated acidity in cancer immunotherapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2018, v. 67, n. 9, p. 1331, doi. 10.1007/s00262-018-2195-z
- By:
- Publication type:
- Article
Reversal of pre-existing NGFR-driven tumor and immune therapy resistance.
- Published in:
- Nature Communications, 2020, v. 11, n. 1, p. 1, doi. 10.1038/s41467-020-17739-8
- By:
- Publication type:
- Article
Addition of interleukin-2 overcomes resistance to neoadjuvant CTLA4 and PD1 blockade in ex vivo patient tumors.
- Published in:
- Science Translational Medicine, 2022, v. 14, n. 642, p. 1, doi. 10.1126/scitranslmed.abj9779
- By:
- Publication type:
- Article
Time Trends in the Treatment and Survival of 5036 Uveal Melanoma Patients in The Netherlands over a 30-Year Period.
- Published in:
- Cancers, 2023, v. 15, n. 22, p. 5419, doi. 10.3390/cancers15225419
- By:
- Publication type:
- Article
A Survival Tree of Advanced Melanoma Patients with Brain Metastases Treated with Immune Checkpoint Inhibitors.
- Published in:
- Cancers, 2023, v. 15, n. 11, p. 2922, doi. 10.3390/cancers15112922
- By:
- Publication type:
- Article
Trends in Incidence and Survival of 1496 Patients with Mucosal Melanoma in The Netherlands (1990–2019).
- Published in:
- Cancers, 2023, v. 15, n. 5, p. 1541, doi. 10.3390/cancers15051541
- By:
- Publication type:
- Article
Adjuvant BRAF-MEK Inhibitors versus Anti PD-1 Therapy in Stage III Melanoma: A Propensity-Matched Outcome Analysis.
- Published in:
- Cancers, 2023, v. 15, n. 2, p. 409, doi. 10.3390/cancers15020409
- By:
- Publication type:
- Article
Systemic Therapy in Advanced Nodular Melanoma versus Superficial Spreading Melanoma: A Nation-Wide Study of the Dutch Melanoma Treatment Registry.
- Published in:
- Cancers, 2022, v. 14, n. 22, p. 5694, doi. 10.3390/cancers14225694
- By:
- Publication type:
- Article
Hospital Variation in Cancer Treatments and Survival OutComes of Advanced Melanoma Patients: Nationwide Quality Assurance in The Netherlands.
- Published in:
- Cancers, 2021, v. 13, n. 20, p. 5077, doi. 10.3390/cancers13205077
- By:
- Publication type:
- Article
Toxicity, Response and Survival in Older Patients with Metastatic Melanoma Treated with Checkpoint Inhibitors †.
- Published in:
- Cancers, 2021, v. 13, n. 11, p. 2826, doi. 10.3390/cancers13112826
- By:
- Publication type:
- Article
Age Does Matter in Adolescents and Young Adults versus Older Adults with Advanced Melanoma; A National Cohort Study Comparing Tumor Characteristics, Treatment Pattern, Toxicity and Response.
- Published in:
- Cancers, 2020, v. 12, n. 8, p. 2072, doi. 10.3390/cancers12082072
- By:
- Publication type:
- Article
Metastatic Uveal Melanoma: Treatment Strategies and Survival—Results from the Dutch Melanoma Treatment Registry.
- Published in:
- Cancers, 2019, v. 11, n. 7, p. 1007, doi. 10.3390/cancers11071007
- By:
- Publication type:
- Article
High-throughput identification of antigen-specific TCRs by TCR gene capture.
- Published in:
- Nature Medicine, 2013, v. 19, n. 11, p. 1534, doi. 10.1038/nm.3359
- By:
- Publication type:
- Article
Adjuvant treatment with anti‐PD‐1 in acral melanoma: A nationwide study.
- Published in:
- International Journal of Cancer, 2024, v. 155, n. 8, p. 1455, doi. 10.1002/ijc.35060
- By:
- Publication type:
- Article
A prediction model for response to immune checkpoint inhibition in advanced melanoma.
- Published in:
- International Journal of Cancer, 2024, v. 154, n. 10, p. 1760, doi. 10.1002/ijc.34853
- By:
- Publication type:
- Article
Time interval from primary melanoma to first distant recurrence in relation to patient outcomes in advanced melanoma.
- Published in:
- International Journal of Cancer, 2023, v. 152, n. 12, p. 2493, doi. 10.1002/ijc.34479
- By:
- Publication type:
- Article
The unfavorable effects of COVID‐19 on Dutch advanced melanoma care.
- Published in:
- International Journal of Cancer, 2022, v. 150, n. 5, p. 816, doi. 10.1002/ijc.33833
- By:
- Publication type:
- Article
Synchronous BRAF<sup>V600E</sup>and MEK inhibition leads to superior control of murine melanoma by limiting MEK inhibitor induced skin toxicity.
- Published in:
- OncoTargets & Therapy, 2013, v. 6, p. 1649, doi. 10.2147/OTT.S52552
- By:
- Publication type:
- Article